← Back to Clinical Trials
Recruiting NCT06738537
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
Trial Parameters
Condition Mitral Valve Prolapse
Sponsor Northwell Health
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2023-09-01
Completion 2024-01-28
Interventions
Focus Groups/Quantitative Survey for PatientsFocus Group/Quantitative Survey for HCPsQualitative Focus Group
Brief Summary
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
Eligibility Criteria
Inclusion Criteria: * Age 21 years and older * Diagnosis of degenerative mitral valve regurgitation Exclusion Criteria: * Non-English speaking * Unable to consent on own behalf * Previous mitral surgery
Related Trials
NCT05631730
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhy
View Trial →
NCT06738537
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
View Trial →
NCT07384871
AI-Based Shape and Function Analysis of Mitral Valve Prolapse Using 3D Ultrasound
View Trial →